Table 1. The clinical parameters in TCGA OV cohort.
| Characteristics | Percentage | |
|---|---|---|
| Age | ≤65 | 260 (68.6%) |
| >65 | 119 (31.4%) | |
| Stage | Stages I–II | 24 (6.33%) |
| Stages III–IV | 352 (92.88%) | |
| Unknown | 3 (0.79%) | |
| Lymphatic_invasion | No | 48 (12.66%) |
| Unknown | 230 (60.69%) | |
| Yes | 101 (26.65%) | |
| Grade | G1 | 1 (0.26%) |
| G2 | 45 (11.87%) | |
| G3 | 322 (84.96%) | |
| Unknown | 11 (2.9%) | |
| Person_neoplasm_cancer_status | Tumor free | 84 (22.16%) |
| unknown | 48 (12.66%) | |
| With tumor | 247 (65.17%) | |
| Primary_therapy_outcome_success | CR+PR | 256 (67.55%) |
| PD+SD | 49 (12.92%) | |
| Unknown | 74 (19.53%) | |
| Tumor_residual_disease | >10 mm | 97 (25.59%) |
| 1–10 mm | 171 (45.12%) | |
| 0 mm | 67 (17.68%) | |
| unknown | 44 (11.61%) |